Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | ||
|---|---|---|---|---|---|
| 1 | 2 | 3 | |||
| Anaphylactic shock | x | ||||
| Angioedema | x | x | |||
| Infection | x | ||||
| Contusion | x | ||||
| Oedema | x | x | x | ||
| Exophthalmos | x | ||||
| Eye disorder | x | ||||
| Haemorrhage | x | ||||
| Hypersensitivity | x | x | x | ||
| Inflammation | x | ||||
| Pain | x | ||||
| Erythema | x | ||||
| Urticaria | x | x | |||
| Periorbital oedema | x | ||||
| Conjunctival oedema | x | ||||
| Injection site reaction | x | x | |||
| Visual acuity reduced | x | ||||
| Chemosis | x | ||||
| Vision blurred | x | ||||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||||
|---|---|---|---|---|---|
| Postpartum haemorrhage | x | ||||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |